Moreover, anti-TIGIT inhibitors could prevent T cell exhaustion [77], reduce tumor cell growth rate, prolong survival, and prevent myeloma escape after stem cell transplantation in mice with MM [78]. This evidence concerns the gene TIGIT and Miyoshi myopathy.